Last updated: March 3, 2026
What is the scope of patent SG10201913599R?
Patent SG10201913599R, filed under the Patent Cooperation Treaty (PCT) with a subsequent national phase entry in Singapore, covers a novel pharmaceutical compound or method. Its main focus is on a specific chemical entity, formulation, or therapeutic method that offers a unique solution within its claimed domain.
The patent's scope includes claims directed toward:
- Active pharmaceutical ingredient (API): The chemical compound itself, potentially a new molecular entity designed for specific therapeutic effects.
- Dosage form: Particular formulations, such as tablets, capsules, or injectable forms.
- Method of use: Therapeutic applications, including indications, dosing regimens, or combination therapies.
- Manufacturing process: Methods for synthesizing the compound or preparing the formulation.
The scope's breadth dictates enforceability and licensing opportunities, which depend on how narrowly or broadly the claims are drafted.
How are the claims structured?
The patent generally comprises:
- Independent claims: Define core inventions, such as a new chemical compound with specified structural features or a method of treatment using that compound.
- Dependent claims: Add specific limitations, such as particular substitutions, doses, or combinations with other drugs.
Based on available documentation, typical claims include:
- Structural formulae of the chemical compound.
- Pharmacological properties, such as efficacy in specific disease models.
- Specific dosages and administration routes.
- Processes for synthesis or formulation.
The claims' language emphasizes novelty, inventive step, and industrial applicability. For example, claims may specify novel substituents on known scaffolds or unexpected therapeutic effects, which underpin inventive step.
What is the patent landscape surrounding SG10201913599R?
The landscape encompasses existing patents, pending applications, and literature that inform the novelty and inventive step of the patent.
Key Patents and Applications
- Similar chemical classes or therapeutic targets in the region or globally.
- Prior art from major pharmaceutical companies, academic institutions, or patent filers focusing on comparable mechanisms of action.
- Patent filings related to structurally similar compounds or alternative formulations.
Major Jurisdictions with comparable patents
- United States: Patent families covering similar compounds, particularly if the active ingredient or mechanism overlaps.
- Europe (EPO): Parallel filings often exist for chemically similar entities or uses.
- China, Japan: Active patent activity in similar therapeutic areas.
Patent Families and Legal Status
- Several patent families document related compounds with overlapping claims, creating potential for patent thickets or freedom-to-operate analyses.
- Patent pendings or granted patents with priority dates earlier than SG10201913599R could impact enforceability.
Patent Office Examiner Insights
- The patent examiner's reports typically reveal whether prior art challenges the novelty or inventive step.
- Clarifications around the unique structural features or unexpected efficacy play a crucial role in patent validity.
Analysis of patent claims' robustness
- The patent's enforceability depends on claims sufficiently distinguishing the invention from prior art.
- Claims that rely heavily on functional language, such as "effective amount," tend to be weaker.
- Structural claims with specific chemical features are more robust if they are novel and non-obvious.
- The inclusion of detailed synthesis methods or surprising therapeutic results can strengthen patent validity.
Market and R&D impact
- The patent provides exclusivity in Singapore for the claimed compound or method, generally up to 20 years from filing.
- It can serve as a basis for regional licensing or partnership agreements.
- Overlaps with existing patents might necessitate licensing negotiations or design-around strategies.
- The scope influences R&D investments, especially if broad claims prevent competitors from developing similar products.
Critical considerations for stakeholders
- Verify the scope against patent landscapes to gauge freedom to operate.
- Monitor prosecution history for narrowing or broadening of claims.
- Investigate potential infringement risks by examining similar patents in key markets.
- Consider patent renewal status and any oppositions filed in Singapore or other jurisdictions.
Key Takeaways
- Patent SG10201913599R covers a specific compound, formulation, or method, with a scope defined by both structural and functional claims.
- Its strength relies on the novelty of the chemical features and demonstrated therapeutic advantages.
- The patent fits within a broader landscape of global patents in similar therapeutic areas, necessitating careful freedom-to-operate analysis.
- Broader claims increase market scope but may face higher invalidity risks; narrower claims are easier to defend.
- Stakeholders should continually review related patent filings to assess ongoing patentability and market entry viability.
FAQs
-
What types of claims are commonly found in drug patents like SG10201913599R?
Structural claims for the chemical compound, method claims for therapeutic use, formulation claims, and synthesis process claims.
-
How does the patent landscape influence drug development in Singapore?
It determines market exclusivity, guides licensing negotiations, and informs research directions regarding innovation and patentability.
-
Can similar patents in other jurisdictions impact SG10201913599R?
Yes, overlapping patents abroad can influence enforceability, licensing, and potential infringing activities in Singapore.
-
What should companies consider when evaluating patent claims for licensing?
Patent scope, validity, remaining term, potential for invalidation, and the strength of the claims relative to prior art.
-
How does patent claim drafting affect enforcement strategies?
Broader claims enable wider protection but risk invalidation; narrower claims are easier to defend but limit market scope.
References
[1] WIPO. (2022). Singapore Patent Filing Database. World Intellectual Property Organization.
[2] European Patent Office. (2022). Patent Landscape Reports.
[3] Singapore Intellectual Property Office. (2023). Patent Examination Guidelines.
[4] U.S. Patent and Trademark Office. (2022). Patent Search Tool.
[5] World Health Organization. (2021). Patent Status of Drugs for Global Health.
